Amalia Eri, Diantini Ajeng, Subarnas Anas
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java 45363, Indonesia.
Oncol Lett. 2020 Nov;20(5):274. doi: 10.3892/ol.2020.12137. Epub 2020 Sep 21.
Bee products are best known as one of the beneficial natural products providing multiple pharmacological effects, such as antimicrobial, antiviral, anti-inflammatory and anticancer effects. The present study aimed to identify potent products derived from the stingless bee spp. from Luwu Utara (South Sulawesi, Indonesia), focussing on the water-soluble extract of propolis and bee pollen, against the proliferation of the human breast cancer MCF-7 cell line. The results from DPPH (2,2-diphenyl-1-picrylhydrazyl) method of antioxidant assay revealed that water-soluble propolis and bee pollen had high antioxidant activity, with half-maximal effective concentrations against DPPH radicals of 1.3 and 0.4 mg/ml, respectively. Additionally, water-soluble propolis and bee pollen exhibited a significant antiproliferative activity in MCF-7 cells, with IC values of 10.8±0.06 and 18.6±0.03 mg/ml, respectively (P<0.05). Significant cytotoxic effects were observed after 24 h of treatment via microscopic and flow cytometric analysis, where a morphological change toward late apoptosis was observed. By contrast, honey had low antioxidant activity and no antiproliferative effect in MCF-7 cells. The water-soluble propolis also exerted its antiproliferative effect in the human keratinocyte HaCaT cell line. The antiproliferative activity was similar (P>0.05) at 24 and 48 h of treatment, with IC at 2.7±0.06 mg/ml and <0.4 mg/ml, respectively. Notably, bee pollen was less toxic to HaCaT cells after 24 h of treatment than the water-soluble propolis, with IC>50 mg/ml. Its antiproliferative activity was significantly increased after 48 h of treatment, with IC at 9.6±0.07 mg/ml (P<0.05). In addition, similar to other poplar propolis, the high-performance liquid chromatography-ultraviolet and electrospray ionisation mass spectrometry analyses revealed that caffeic acid phenethyl ester was not the main bioactive compound of the samples examined. Furthermore, two major proteins (between ~50 and 75 kDa) were identified in the water-soluble propolis and bee pollen. The present results suggested that water-soluble propolis and bee pollen may have the potential to be elaborated further as a breast anticancer therapy.
蜂产品作为具有多种药理作用的有益天然产品之一而广为人知,比如具有抗菌、抗病毒、抗炎和抗癌作用。本研究旨在鉴定源自印度尼西亚南苏拉威西省北卢武的无刺蜂属的有效产品,重点关注蜂胶和蜂花粉的水溶性提取物对人乳腺癌MCF-7细胞系增殖的影响。抗氧化分析的DPPH(2,2-二苯基-1-苦基肼)法结果显示,水溶性蜂胶和蜂花粉具有高抗氧化活性,对DPPH自由基的半数有效浓度分别为1.3和0.4毫克/毫升。此外,水溶性蜂胶和蜂花粉在MCF-7细胞中表现出显著的抗增殖活性,IC值分别为10.8±0.06和18.6±0.03毫克/毫升(P<0.05)。通过显微镜和流式细胞术分析,在处理24小时后观察到显著细胞毒性作用,其中观察到向晚期凋亡的形态变化。相比之下,蜂蜜抗氧化活性低,对MCF-7细胞无抗增殖作用。水溶性蜂胶在人角质形成细胞HaCaT细胞系中也发挥其抗增殖作用。在处理24小时和48小时时抗增殖活性相似(P>0.05),IC值分别为2.7±0.06毫克/毫升和<0.4毫克/毫升。值得注意的是,处理24小时后,蜂花粉对HaCaT细胞的毒性低于水溶性蜂胶,IC>50毫克/毫升。处理48小时后其抗增殖活性显著增加,IC值为9.6±0.07毫克/毫升(P<0.05)。此外,与其他杨树蜂胶类似,高效液相色谱-紫外和电喷雾电离质谱分析显示,咖啡酸苯乙酯不是所检测样品的主要生物活性化合物。此外,在水溶性蜂胶和蜂花粉中鉴定出两种主要蛋白质(约50至75 kDa之间)。目前的结果表明,水溶性蜂胶和蜂花粉可能有进一步开发为乳腺癌治疗方法的潜力。